Shreyaskumar Patel

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

(2023)10.1158/1078-0432.c.6532743

Top 100%

0DataRank

Top 100%0 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

Papers

Driven by 20 papers — median percentile 0. Top paper: “SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma”.

SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma

Cancer(2020)10.1002/cncr.33349

N/A

1.4DataRank · unranked

47 citations

Karla V. Ballman, Lee J. Helman, Shreyaskumar Patel, Jeremy Whelan, Brigitte C. Widemann +9 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232

N/A

0.749DataRank · unranked

146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer(2024)10.1038/s43018-024-00726-z

N/A

0.612DataRank · unranked

58 citations

Elise F. Nassif, Emily Z. Keung, Wei‐Lien Wang, Alexander J. Lazar, Heather Lin +54 more

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers

Cancers(2020)10.3390/cancers12071768

N/A

0.542DataRank · unranked

36 citations

Ajaykumar C. Morani, Najat C. Daw, Salah-Eddine Lamhamedi-Cherradi, Vivek Subbiah, Brian A. Menegaz +22 more

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2145

N/A

0.416DataRank · unranked

15 citations

Naoko Takebe, Shivaani Kummar, Albiruni R. Abdul Razak, Sant P. Chawla, Suzanne George +13 more

Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1703

N/A

0.373DataRank · unranked

11 citations

Richard K. Yang, Alexander J. Lazar, Shalin S. Patel, Valerae O. Lewis, Jason Roszik +13 more

The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol

Neurosurgical Focus(2024)10.3171/2024.2.focus2416

N/A

0.312DataRank · unranked

7 citations

Shaan M. Raza, Misha Amini, Scott Seaman, Franco Rubino, Rita Snyder +4 more

Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

Frontiers in Immunology(2025)10.3389/fimmu.2025.1567736

N/A

0.269DataRank · unranked

5 citations

Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis R. Ingram, Khalida Wani +21 more

TFCP2 Fusion-Positive Rhabdomyosarcomas: A Report of 10 Cases and a Review of the Literature

Cancers(2025)10.3390/cancers17091441

N/A

0.241DataRank · unranked

4 citations

Ryan A. Denu, Davis R. Ingram, Khalida Wani, Alexander J. Lazar, Douglas J. Harrison +5 more

Hyalinization-based pathologic response and immune infiltration following neoadjuvant radiotherapy with or without immune-checkpoint blockade in localized undifferentiated pleomorphic sarcoma

ESMO Open(2025)10.1016/j.esmoop.2025.105493

N/A

0.104DataRank · unranked

1 citations

Mohamad El Zoghbi, Rossana Lazcano, Brandon Cope, Andrew J. Bishop, Ahsan Farooqi +24 more

Data from Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

(2023)10.1158/1078-0432.c.6532743

Top 100%

0DataRank

Top 100%0 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

Data from Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

(2023)10.1158/1078-0432.c.6532743.v1

Top 100%

0DataRank

Top 100%0 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies

OncoTargets and Therapy(2021)10.2147/ott.s291801

N/A

0DataRank · unranked

3 citations

Ecaterina E. Dumbrava, Binoj C. Nair, Wendy Xiong, Xu Li, Rosa Mostorino +12 more

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0761

N/A

0DataRank · unranked

3 citations

Ian M. Silverman, Victoria Rimkunas, Artur Veloso, Dominik Głodzik, Adrienne Johnson +16 more

Impact of ATRX loss on survival and immune microenvironment in multiple sarcoma subtypes.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11511

N/A

0DataRank · unranked

3 citations

Rossana Lazcano Segura, Ahsan Farooqi, Davis R. Ingram, Khalida Wani, Yiming Cai +13 more

ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.23.689992

N/A

0DataRank · unranked

0 citations

Anand K. Singh, Yingda Jiang, Zheng Zhao, Davis R. Ingram, Khalida Wani +28 more

Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2509

N/A

0DataRank · unranked

9 citations

Roberto Carmagnani Pestana, Jason Roszik, David S. Hong, Aung Naing, Siqing Fu +18 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618

N/A

0DataRank · unranked

229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3629

N/A

0DataRank · unranked

21 citations

Justin T. Moyers, Jason Roszik, Shiraj Sen, David S. Hong, Aung Naing +29 more

Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma

Neurosurgery(2021)10.1093/neuros/nyaa398_s099

N/A

0DataRank · unranked

1 citations

Hadley E. Sheppard, Visweswaran Ravikumar, Jonathan D. Breshears, Shaan M. Raza, Charles Y. Lin +3 more

Shreyaskumar Patel

Indexed papers

Top data-sharing exemplar

Papers